Coronary Artery Calcification and Calcium Intake

Pathophysiology and Atherosclerosis Burden

The process of coronary artery calcification begins with atherosclerosis progression from intimal thickening to foam-cell and lipid-pool accumulation, eventually forming fibroatheromas, with cycles of fibroatheroma erosion, rupture, and healing creating fibrocalcified plaques 1
The extent of calcification correlates with total coronary plaque burden, but calcification itself is neither an indicator of plaque stability nor instability 2
CAC serves as a reliable marker of coronary atherosclerosis and vascular age, with the CAC area representing only 20% of the total atherosclerosis burden because not all plaques contain calcium 1

Multiple high-quality studies demonstrate that dietary calcium intake, even at high levels, does not increase coronary artery calcification or cardiovascular risk, with the American Heart Association likely to recommend adequate dietary calcium intake for cardiovascular health 3
The Multi-Ethnic Study of Atherosclerosis showed that high total calcium intake was associated with decreased risk of incident CAC, particularly when achieved without supplements, according to the National Institutes of Health 3
Neither the Framingham Heart Study nor the WHI trial showed a relationship between calcium supplement use and coronary calcium scores, as reported by the National Institutes of Health 3

In CKD patients, excessive calcium intake from phosphate binders combined with impaired mineral metabolism creates a unique risk for vascular calcification through elevated calcium-phosphate product, with the National Kidney Foundation recommending careful management of calcium intake in CKD patients 4
The calcium-phosphate product above 55 mg²/dL² is associated with increased risk of soft tissue and vascular calcification in CKD patients, with the American Journal of Kidney Diseases recommending close monitoring of calcium-phosphate product in CKD patients 6
Total elemental calcium intake from all sources must not exceed 2,000 mg/day in dialysis patients, with calcium from binders alone ideally remaining under 1,500 mg/day, as recommended by the American Journal of Kidney Diseases 5

CAC should be viewed primarily as a marker of atherosclerosis burden rather than degree of stenosis, as lumen patency is often preserved by vascular remodeling, with the American College of Cardiology recommending the use of CAC scores in cardiovascular risk assessment 1
Patients with CAC ≥ 1000 have an overall death or MI rate of approximately 17.9% and should receive aggressive preventive interventions, including lifestyle modifications and medical therapy, as recommended by the European Society of Cardiology 7